Clinically relevant molecular subtypes in leiomyosarcoma

PURPOSE: Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. Recognition of different molecular subtypes is necessary to evaluate novel therapeutic options. In a previous...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Cancer Res
Hlavní autoři: Guo, Xiangqian, Jo, Vickie Young, Mills, Anne M., Zhu, Shirley X., Lee, Cheng-Han, Espinosa, Inigo, Nucci, Marisa Rose, Varma, Sushama, Forgó, Erna, Hastie, Trevor, Anderson, Sharon, Ganjoo, Kristen, Beck, Andrew H., West, Robert B., Fletcher, Christopher, van de Rijn, Matt
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526352/
https://ncbi.nlm.nih.gov/pubmed/25896974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-3141
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky